Li Jiabei, Fu Wuchang, Wang Na, Zeng Sisi, Li Xuechao, Wan Jixiang, Wang Fangjun
Department of Anesthesiology, Affiliated Hospital of North Sichuan Medical College, Nanchong, People's Republic of China.
Department of Anesthesiology, Meishan City People's Hospital, Meishan, People's Republic of China.
Drug Des Devel Ther. 2025 Jan 9;19:129-140. doi: 10.2147/DDDT.S494162. eCollection 2025.
To determine the effect of dexmedetomidine on the ED and ED of sufentanil in patient-controlled intravenous analgesia (PCIA) after cesarean section.
Parturients who underwent elective cesarean section (n = 80) were randomly assigned to either the sufentanil group (S group) or the dexmedetomidine-sufentanil combination group (DS group). Patients in the S group received a combination of sufentanil, 5 mg of tropisetron, and saline, whereas patients in the DS group were administered 1.5µg/kg of dexmedetomidine in addition to sufentanil, 5 mg of tropisetron, and saline. The ED and ED of sufentanil were determined by Dixon sequential method. We used probit regression to calculate the ED, ED, and 95% confidence intervals for sufentanil in each group.
The ED and ED for sufentanil in the S group were 1.634 (95% CI: 1.476-1.810)µg/kg and 2.035 (95% CI: 1.841-3.312)µg/kg, respectively. The ED and ED for sufentanil in the DS group were 1.275 (95% CI: 1.187-1.353)µg/kg and 1.503 (95% CI: 1.406-1.824)µg/kg. The VAS scores with rest at t and with movement at t- t were lower in the DS group (< 0.05). The t-t Ramsay scores in the DS group were higher than those in the S group (< 0.05). The doses of sufentanil and tramadol were markedly reduced in the DS group, while the onset of first lactation occurred significantly earlier in the DS group (< 0.05). Compared with the S group, the DS group had a lower incidence of nausea, vomiting, and skin itching (< 0.05), and lower frequency of patient-controlled analgesia (PCA) episodes (< 0.05), and better postoperative pain satisfaction (< 0.05).
The 1.5µg/kg dexmedetomidine can significantly decrease the ED and ED of sufentanil in patient-controlled intravenous analgesia after cesarean section, provide good postoperative analgesia and sedation, and promote the earlier occurrence of first lactation.
确定右美托咪定对剖宫产术后患者自控静脉镇痛(PCIA)中舒芬太尼半数有效剂量(ED)和95%有效剂量(ED95)的影响。
择期行剖宫产的产妇(n = 80)被随机分为舒芬太尼组(S组)或右美托咪定 - 舒芬太尼联合组(DS组)。S组患者接受舒芬太尼、5 mg托烷司琼和生理盐水的联合用药,而DS组患者除舒芬太尼、5 mg托烷司琼和生理盐水外,还给予1.5µg/kg右美托咪定。采用Dixon序贯法确定舒芬太尼的ED和ED95。我们使用概率回归计算每组中舒芬太尼的ED、ED95和95%置信区间。
S组中舒芬太尼的ED和ED95分别为1.634(95%CI:1.476 - 1.810)µg/kg和2.035(95%CI:1.841 - 3.312)µg/kg。DS组中舒芬太尼的ED和ED95分别为1.275(95%CI:1.187 - 1.353)µg/kg和1.503(95%CI:1.406 - 1.824)µg/kg。DS组在t时刻静息时和t - t时刻活动时的视觉模拟评分(VAS)较低(<0.05)。DS组的t - t Ramsay评分高于S组(<0.05)。DS组中舒芬太尼和曲马多的剂量显著降低,而DS组首次泌乳开始时间显著更早(<0.05)。与S组相比,DS组恶心、呕吐和皮肤瘙痒的发生率较低(<0.05),患者自控镇痛(PCA)发作频率较低(<0.05),术后疼痛满意度较好(<0.05)。
1.5µg/kg右美托咪定可显著降低剖宫产术后患者自控静脉镇痛中舒芬太尼的ED和ED95,提供良好的术后镇痛和镇静效果,并促进首次泌乳更早发生。